Publications by authors named "Brian P Booth"

Claim this Profile
U
Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development.
Huiming Xia, Brian P Booth, Yaning Wang, Chunling Fan, Vishal Bhatnagar

J Patient Rep Outcomes· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Land O'Lakes Workshop on Microsampling: Enabling Broader Adoption.
Enaksha R Wickremsinhe, Qin C Ji, Carol R Gleason, Melanie Anderson, Brian P Booth

AAPS J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid assays: the next big thing?
Brian P Booth, Brian Furmanski

Bioanalysis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response.
Hongshan Li, Jingyu Yu, Chao Liu, Jiang Liu, Sriram Subramaniam, Brian P Booth

J Pharmacokinet Pharmacodyn· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: metabolites in safety testing (MIST) symposium-safety assessment of human metabolites: what's REALLY necessary to ascertain exposure coverage in safety tests?
Hongying Gao, Abigail Jacobs, Ronald E White, Brian P Booth, R Scott Obach

AAPS J· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conference report: emerging technology for bioanalysis in the next decade.
James E Demuth, Qin C Ji, Brian P Booth, Eric N Fluhler, Roger Greathead

Bioanalysis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.
Joseph A Grillo, Ping Zhao, Julie Bullock, Brian P Booth, Min Lu

Biopharm Drug Dispos· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections.
Fabio Garofolo, Mario L Rocci, Isabelle Dumont, Suzanne Martinez, Steve Lowes, Brian P Booth

Bioanalysis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance.
Natasha Savoie, Fabio Garofolo, Peter van Amsterdam, Surendra Bansal, Chris Beaver, Brian P Booth

Bioanalysis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop.
Natasha Savoie, Fabio Garofolo, Peter van Amsterdam, Brian P Booth, Douglas M Fast

Bioanalysis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10th Annual University of Wisconsin Land O'Lakes Bioanalytical Conference.
James E DeMuth, Mark E Arnold, Brian P Booth, Eric Fluhler, Russell Grant

Bioanalysis· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
Edwin P Rock, John Finkle, Howard J Fingert, Brian P Booth, Christine E Garnett

Am Heart J· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.
Natasha Savoie, Brian P Booth, Troy Bradley, Fabio Garofolo, Nicola C Hughes

Bioanalysis· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma.
Bhupinder S Mann, John R Johnson, Kun He, Rajeshwari Sridhara, Sophia Abraham, Brian P Booth

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
Vicki L Goodman, Edwin P Rock, Ramzi Dagher, Roshni P Ramchandani, Sophia Abraham, Brian P Booth

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of SN-38 exposure, UGT1A1*28 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity.
Roshni P Ramchandani, Yaning Wang, Brian P Booth, Amna Ibrahim, John R Johnson

J Clin Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.
Brian P Booth, Atiqur Rahman, Ramzi Dagher, Donna Griebel, Shari Lennon

J Clin Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Martin H Cohen, John R Johnson, Tristan Massie, Rajeshwari Sridhara, W David McGuinn, Brian P Booth

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications.
Venkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, B Nhi Beasley, Yaning Wang

AAPS J· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed in malignant pleural mesothelioma.
Maitreyee Hazarika, Robert M White, Brian P Booth, Yong-Cheng Wang, Doo Y Lee Ham

Clin Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations in analyzing single-trough concentrations using mixed-effects modeling.
Brian P Booth, Jogarao V S Gobburu

J Clin Pharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis